Veraxa Biotech Holding AG (VRXA) Debt to Equity (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted Debt to Equity of -$0.03 for Q4 2025, up 99.69% on a QoQ basis from -$9.44 in Q4 2024, and up 99.69% YoY from -$0.01 in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Debt to Equity (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Debt to Equity for 2 consecutive years, with -$0.03 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity rose 99.69% year-over-year to -$0.03; the trailing twelve-month figure through Dec 2025 stood at -$0.03 (up 99.69% YoY), and the FY2025 full-year result was -$0.03, up 99.69% from the prior year.
- Debt to Equity improved to -$0.03 in Q4 2025 per VRXA's latest filing, from -$9.44 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.03 in Q4 2025 to a low of -$9.44 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03 |
| Dec 31, 2024 | -9.44 |